< Back to previous page
Researcher
Diether Lambrechts
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Morphological sciences, Oncology
- See also: Diether Lambrechts (KU Leuven)
Affiliations
- Laboratory of Translational Genetics (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - VIB-KU Leuven Center for Cancer Biology (Research Center)
Responsible
From1 Jan 2017 → Today - Lambrechts Lab (Research group)
Responsible
From1 Jan 2017 → Today - Laboratory of Translational Genetics (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → Today - Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 2003 → 30 Sep 2005 - Department of Cellular and Molecular Medicine (Department)
Member
From1 Oct 1999 → 30 Sep 2003
Projects
1 - 7 of 7
- EXPANDing Immune Cells and their Tumor Antigens during checkpoint immunotherapyFrom1 Jan 2023 → TodayFunding: HORIZON.1.1 - European Research Council (ERC)
- VIB Grant for Lambrechts Lab_Period:2022-01-01-2026-12-31From1 Jan 2022 → TodayFunding: FRI - Project driven research
- CIRCULATING TUMOR DNA AS AN EPIGENETIC BIOMARKER FOR TUMOR RESPONSE’ — ‘INITIATOR’ - ERC POCFrom1 Aug 2020 → 31 Jan 2022Funding: HORIZON.1.1 - European Research Council (ERC)
- RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.’ — ‘RESCUER’From1 Jan 2020 → TodayFunding: Other EU initiatives out of framework
- 'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’From1 Jan 2018 → 31 Dec 2022Funding: Other EU initiatives out of framework
- Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics (GLIOTRAIN) - Marie Sklodowska-Curie actions (ITN)From1 Sep 2017 → 31 Aug 2021Funding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- VIB Grant for Lambrechts Lab_Period:2017-01-01-2021-12-31From1 Jan 2017 → 31 Dec 2021Funding: FRI - Project driven research
Publications
21 - 30 of 230
- A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.(2023)
Authors: Diether Lambrechts
Pages: 93 - C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps.(2023)
Authors: Pierre Van Mol, Diether Lambrechts
Pages: 12 - Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.(2023)
Authors: Diether Lambrechts
Pages: 1956 - Ethanol induces replication fork stalling and membrane stress in immortalized laryngeal cells.(2023)
Authors: Lore Hoes, Karin Voordeckers, Bram Boeckx, Diether Lambrechts, Kevin Verstrepen
Pages: 108564 - Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.(2023)
Authors: Diether Lambrechts
Pages: 1186-1197 - Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells.(2023)
Authors: Diether Lambrechts, Gonca Dilcan Durdag, Francesca Lodi
Pages: 15678 - Organoids from mouse molar and incisor as new tools to study tooth-specific biology and development.(2023)
Authors: Diether Lambrechts
Pages: 1-16 - Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.(2023)
Authors: Diether Lambrechts
Pages: 16142-16162 - Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection.(2023)
Authors: Amelie Franken, Diether Lambrechts
Pages: 4359 - PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma.(2023)
Authors: Sarah Cappuyns, Bram Boeckx, Aurelie Mechels, Ayse Bassez, Francesca Lodi, Orian Bricard, Junbin Qian, Diether Lambrechts
Pages: 7825
Patents
1 - 10 of 10
- DISEASE DETECTION IN LIQUID BIOPSIES (Inventor)
- BIOMARKERS PREDICTING RESPONSE OF BREAST CANCER TO IMMUNOTHERAPY (Inventor)
- DISEASE DETECTION IN LIQUID BIOPSIES (Inventor)
- PREDICTING CHRONIC ALLOGRAFT INJURY THROUGH AGE-RELATED DNA METHYLATION (Inventor)
- PREDICTING CHRONIC ALLOGRAFT INJURY THROUGH AGE-RELATED DNA METHYLATION (Inventor)
- RETROTRANSPOSON BIOMARKERS (Inventor)
- RETROTRANSPOSON BIOMARKERS (Inventor)
- DISEASE DETECTION IN LIQUID BIOPSIES (Inventor)
- DETECTION OF OVARIAN CANCER IN LIQUID BIOPSIES (Inventor)
- PREDICTING CHRONIC ALLOGRAFT INJURY THROUGH AGE-RELATED DNA METHYLATION (Inventor)